News | January 25, 2010

FDA to Re-Assess Premarket Clearance for Medical Devices

The Wiimote may find some uses in the medical field.

January 25, 2010 - With more than 3,000 requests for medical devices to get 510(k) clearance each year, the U.S. Food and Drug Administration (FDA) asked the Institute of Medicine (IOM) to conduct a comprehensive study of the process, which is not scheduled to be concluded for another year.

In the meantime, the FDA is internally evaluating the quality and consistency in the 510(k) process. To garner public feedback on the matter, the FDA scheduled a public meeting on Feb. 18, 2010, to discuss key challenges related to the premarket notification, or 510(k) process, used to review and clear medical devices marketed in the United States.

The agency established the premarket notification process for medical devices 30 years ago, and now is holding a hearing on the process of approving medical devices, noted Jeffrey Shuren, M.D., J.D., director of FDA’s Center for Devices and Radiological Health.

The FDA staff will highlight issues with previously cleared devices that may support a manufacturer’s claim of substantial equivalence; challenges with assessing new technologies and scientific evidence; managing the high volume of submissions; and postmarket surveillance and new information about marketed devices.

Each of the four overview presentations will be followed by an open comment session. The meeting will be held on February 18,. 2010, meeting will run from 8 a.m. to 5:30 p.m. at the Hilton Washington, D.C./North Gaithersburg, in Gaithersburg, Md. To attend or participate in the meeting you must register by 5 p.m. on Feb. 12, 2010. The agency is accepting written or electronic comments by March 5, 2010.

For more information: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2009/ucm183497...

Related Content

Siemens Healthineers Announces FDA Clearance of syngo.via VB30 Molecular Imaging Software
Technology | Nuclear Imaging | July 16, 2018
At the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 23-26 in Philadelphia...
Breast Cancer Follow-up Imaging Varies Widely
News | Breast Imaging | July 13, 2018
July 13, 2018 — Follow-up imaging for women...
Invision Diagnostics Installs VolparaEnterprise Software to Enhance Mammography Image Quality
News | Mammography | July 11, 2018
Invision Diagnostics, a provider of mobile mammography services across North and South Carolina, announced that it is...
Breast Cancer Studies Ignore Race, Socioeconomic Factors
News | Women's Health | July 11, 2018
A new commentary appearing in the July issue of Cancer Causes & Control points to evidence that social factors help...
Guerbet, IBM Watson Health Partner on Artificial Intelligence for Liver Imaging
News | Clinical Decision Support | July 10, 2018
Guerbet announced it has signed an exclusive joint development agreement with IBM Watson Health to develop an...
Jeffrey Hoffmeister, M.D.

Jeffrey Hoffmeister, M.D.

Feature | Breast Imaging | July 05, 2018 | By Jeffrey Hoffmeister, M.D.
When women reach age 40, an annual mammogram becomes a necessary part of their healthcare ritual — regardless if they...
The images (before and after) depict a 50 percent dose reduction in chest X-ray without compromising  image quality.

The images (before) depict a 50 percent dose reduction in chest X-ray without compromising
image quality.

Sponsored Content | Case Study | Radiation Dose Management | July 03, 2018
There are a handful of priorities for radiologists: lowest radiation dosage, highest image quality, optimal workflow,...
Ensuring that the FMDS for MRI safety is mounted outside Zone IV provides maximum early warning.

Ensuring that the FMDS for MRI safety is mounted outside Zone IV provides maximum early warning. (Images courtesy of Metrasens)

Feature | Magnetic Resonance Imaging (MRI) | July 03, 2018 | By Tobias Gilk
Nearly every job in the country is subject to certain health and safety regulations. Construction workers must wear...
Carestream DRX-Revolution Nano Mobile X-ray System

The Carestream DRX-Revolution Nano Mobile X-ray System.

Feature | Digital Radiography (DR) | July 03, 2018 | By Melinda Taschetta-Millane
The mobile digital radiography (DR) segment is the largest segment by product type in the global digital mobile DR...
Feature | Proton Therapy | July 03, 2018 | By Jeff Zagoudis
The Alliance for Proton Therapy Access (APTA) released a national report in late May revealing the heavy emotional and...
Overlay Init